The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)

Andrew J Molyneux, Jacqueline Birks, Alison Clarke, Mary Sneade, Richard S C Kerr, Andrew J Molyneux, Jacqueline Birks, Alison Clarke, Mary Sneade, Richard S C Kerr

Abstract

Background: Previous analyses of the International Subarachnoid Aneurysm Trial (ISAT) cohort have reported on the risks of recurrent subarachnoid haemorrhage and death or dependency for a minimum of 5 years and up to a maximum of 14 years after treatment of a ruptured intracranial aneurysm with either neurosurgical clipping or endovascular coiling. At 1 year there was a 7% absolute and a 24% relative risk reduction of death and dependency in the coiling group compared with the clipping group, but the medium-term results showed the increased need for re-treatment of the target aneurysm in the patients given coiling. We report the long-term follow-up of patients in this UK cohort.

Methods: In ISAT, patients were randomly allocated to either neurosurgical clipping or endovascular coiling after a subarachnoid haemorrhage, assuming treatment equipoise, between Sept 12, 1994, and May 1, 2002. We followed up 1644 patients in 22 UK neurosurgical centres for death and clinical outcomes for 10·0-18·5 years. We assessed dependency as self-reported modified Rankin scale score obtained through yearly questionnaires. Data for recurrent aneurysms and rebleeding events were collected from questionnaires and from hospital and general practitioner records. The Office for National Statistics supplied data on deaths. This study is registered, number ISRCTN49866681.

Findings: At 10 years, 674 (83%) of 809 patients allocated endovascular coiling and 657 (79%) of 835 patients allocated neurosurgical clipping were alive (odds ratio [OR] 1·35, 95% CI 1·06-1·73). Of 1003 individuals who returned a questionnaire at 10 years, 435 (82%) patients treated with endovascular coiling and 370 (78%) patients treated with neurosurgical clipping were independent (modified Rankin scale score 0-2; OR 1·25; 95% CI 0·92-1·71). Patients in the endovascular treatment group were more likely to be alive and independent at 10 years than were patients in the neurosurgery group (OR 1·34, 95% CI 1·07-1·67). 33 patients had a recurrent subarachnoid haemorrhage more than 1 year after their initial haemorrhage (17 from the target aneurysm).

Interpretation: Although rates of increased dependency alone did not differ between groups, the probability of death or dependency was significantly greater in the neurosurgical group than in the endovascular group. Rebleeding was more likely after endovascular coiling than after neurosurgical clipping, but the risk was small and the probability of disability-free survival was significantly greater in the endovascular group than in the neurosurgical group at 10 years.

Funding: UK Medical Research Council.

Copyright © 2015 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Kaplan-Meier plot of cumulative risk of rebleeding from target (treated) aneurysm later than 1 year after subarachnoid haemorrhage
Figure 2
Figure 2
Kaplan-Meier plot of cumulative mortality Patients observed for 10–18·5 years in 22 UK centres.

References

    1. Molyneux AJ, Kerr RS, Stratton I, for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–1274.
    1. Molyneux AJ, Kerr RS, Yu LM, for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809–817.
    1. Campi A, Ramzi N, Molyneux AJ. Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT) Stroke. 2007;38:1538–1544.
    1. Molyneux AJ, Kerr RS, Birks J, for the ISAT Collaborators Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009;8:427–433.
    1. Shultz F, Altman DG, Moher D, for the CONSORT group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011;9:672–677.
    1. Begg C, Cho M, Eastwood S. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637–639.
    1. ONS Office of National Statistics website. (accessed Oct 10, 2013).
    1. Kunz R, Burnand B. The GRADE System: an international approach to standardize the graduation of evidence and recommendations in guidelines. Internist (Berl) 2008;49:673–680.
    1. White PM, Lewis SC, Gholkar A, for the HELPS trial collaborators Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial. Lancet. 2011;377:1655–1662.
    1. Molyneux AJ, Clarke A, Sneade M. Cerecyte Coil Trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either Cerecyte of bare platinum coils. Stroke. 2012;43:2544–2550.
    1. Kerr R, Molyneux A. Letter to the editor: The Barrow Ruptured Aneurysm Trial and International Subarachnoid Aneurysm Trial. J Neurosurg. 2013;118:478–480.
    1. Langham J, Reeves BC, Lindsay KW. Variation in outcome after subarachnoid haemorrhage: a study of neurosurgical units in UK and Ireland. Stroke. 2009;40:111–118.
    1. NECPOD Managing the flow? (accessed Sept 1, 2014).

Source: PubMed

3
Abonneren